Epoxy resins (EPs) exhibit various extraordinary properties, including significant mechanical and thermal properties, low shrinkage, and high chemical resistance, opening a wide window of different applications such as adhesives, paints, coatings, etc. By contrast, EPs also have the undesirable behavior of being brittle and cannot sufficiently resist against the initiation and growth of cracks. Efforts are being made to enhance the toughening of EPs without sacrificing their other desirable properties. With the advent of nanotechnology, improving the toughening of EPs has gained momentum by incorporating different modified and unmodified nanofillers into these polymers. Since the discovery of carbonaceous nanofillers, especially carbon nanotubes (CNTs) and graphene (Gr), significant progress has been made in the development of EP‐based composites incorporating these nanofillers and their hybrids. The current review presents research progress during the last six years on the toughening of EPs using CNTs, Gr, and CNT‐Gr hybrids. Special attention is given to the chemical functionalization of these nanofillers, which has been demonstrated over and over again to significantly affect nanofiller dispersion in the EP matrix and subsequently its fracture properties. Details on the various toughening mechanisms of EP‐based composites are further provided.

No abstract

Drug repositioning offers an effective solution to drug discovery, saving both time and resources by finding new indications for existing drugs. Typically, a drug takes effect via its protein targets in the cell. As a result, it is necessary for drug development studies to conduct an investigation into the interrelationships of drugs, protein targets, and diseases. Although previous studies have made a strong case for the effectiveness of integrative network-based methods for predicting these interrelationships, little progress has been achieved in this regard within drug repositioning research. Moreover, the interactions of new drugs and targets (lacking any known targets and drugs, respectively) cannot be accurately predicted by most established methods. In this paper, we propose a novel semi-supervised heterogeneous label propagation algorithm named Heter-LP, which applies both local and global network features for data integration. To predict drug-target, disease-target, and drug-disease associations, we use information about drugs, diseases, and targets as collected from multiple sources at different levels. Our algorithm integrates these various types of data into a heterogeneous network and implements a label propagation algorithm to find new interactions. Statistical analyses of 10-fold cross-validation results and experimental analyses support the effectiveness of the proposed algorithm.

No abstract